Blood test for better stomach cancer diagnosis
Part of Cancer, Digestive system clinical trials.
This study is testing whether small molecules in your blood (called 'small non-coding RNAs') can help doctors more accurately diagnose stomach cancer. If you have recently been diagnosed, this study will look for those molecules to see if they can be used as a simple blood test in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have been diagnosed with stomach (gastric) cancer confirmed by a tissue sample (biopsy).
- You have not had any other type of cancer in the last 5 years.
- You have not had surgery (besides a small biopsy) in the past 4 weeks.
- You are not pregnant or breastfeeding.
- You are willing and able to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a blood liquid biopsy test can detect when stomach cancer has spread to the lining of the abdomen (peritoneal metastasis). It compares people with confirmed belly spread to people whose belly lining tests were negative, using blood samples before/around treatment decisions.
This study looks for metabolic markers in your blood and tumor tissue to help find stomach cancer early, predict your prognosis, and watch for recurrence. If you qualify, you would give blood and tumor samples for testing.
This study tracks a simple blood test to look for tiny traces of cancer DNA after stomach cancer surgery. It aims to see if this test can catch any cancer coming back early, so you can get treatment sooner.
This study is looking for people with stomach discomfort who are coming to this hospital for an endoscopy. Researchers will use the test results to help catch stomach cancer early and keep an eye on it after surgery.
This study looks at using a blood test that finds tiny bits of cancer DNA to decide if you need extra chemotherapy after surgery. It aims to make treatment more personalized and reduce side effects for people with locally advanced stomach cancer.
This trial is testing whether using a blood test to find tiny amounts of cancer DNA after initial treatment can guide decisions about further therapy for people with stomach cancer. The goal is to personalize follow-up treatment to reduce the chance of cancer returning.
Hear when a new Stomach Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.